Literature DB >> 11410557

Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.

I I Tulevski1, M Groenink, E E van Der Wall, D J van Veldhuisen, F Boomsma, J Stoker, A Hirsch, J S Lemkes, B J Mulder.   

Abstract

OBJECTIVE: To evaluate the role of plasma neurohormones in the diagnosis of asymptomatic or minimally symptomatic right ventricular dysfunction.
SETTING: Tertiary cardiovascular referral centre.
METHODS: Plasma brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) concentrations were measured in 21 asymptomatic or minimally symptomatic patients with chronic right ventricular pressure overload caused by congenital heart disease, and in seven healthy volunteers. Right ventricular ejection fraction was determined using magnetic resonance imaging.
RESULTS: Right ventricular ejection fraction in the volunteers was higher than in the patients (69.0 (8.2)% v 58.0(12.0)%, respectively; p < 0.006). Left ventricular ejection fraction was 72.3(7.8)% in volunteers and 68.1(11.0)% in patients (NS). There was a significant difference between patients and volunteers in the plasma concentrations of BNP (5.3 (3.5) v 2.3 (1.7) pmol/l, respectively; p < 0.009) and ANP (7.3 (4.5) v 3.6 (1.4) pmol/l; p < 0.05). In both patients and volunteers, mean plasma ANP was higher than mean plasma BNP. Right ventricular ejection fraction was inversely correlated with BNP and ANP (respectively, r = 0.65; p < 0.0002 and r = 0.61; p < 0.002). There was no correlation between left ventricular ejection fraction and BNP (r = 0.2; NS) or ANP (r = 0.52; NS). Similarly, no correlation was shown between the level of right ventricular systolic pressure and either plasma BNP (r = 0.20) or plasma ANP (r = 0.07).
CONCLUSIONS: There was a significant inverse correlation between right ventricular ejection fraction and the plasma neurohormones BNP and ANP in asymptomatic or minimally symptomatic patients with right ventricular pressure overload and congenital heart disease. Monitoring changes in BNP and ANP may provide quantitative follow up of right ventricular dysfunction in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410557      PMCID: PMC1729810          DOI: 10.1136/heart.86.1.27

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

Review 1.  Ventricular performance in congenital heart disease.

Authors:  T P Graham
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

2.  Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.

Authors:  H Berglund; S Boukter; E Theodorsson; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1990-07

Review 3.  Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications.

Authors:  S A Rebergen; E E van der Wall; J Doornbos; A de Roos
Journal:  Am Heart J       Date:  1993-12       Impact factor: 4.749

Review 4.  Evaluation of cardiac function with magnetic resonance imaging.

Authors:  P M Pattynama; A De Roos; E E Van der Wall; A E Van Voorthuisen
Journal:  Am Heart J       Date:  1994-09       Impact factor: 4.749

5.  Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.

Authors:  S Talwar; I B Squire; J E Davies; D B Barnett; L L Ng
Journal:  Eur Heart J       Date:  1999-12       Impact factor: 29.983

6.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.

Authors:  A Lerman; R J Gibbons; R J Rodeheffer; K R Bailey; L J McKinley; D M Heublein; J C Burnett
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

8.  High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.

Authors:  D J van Veldhuisen; S Genth-Zotz; J Brouwer; F Boomsma; T Netzer; A J Man In 'T Veld; Y M Pinto; K I Lie; H J Crijns
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

9.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

10.  Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure.

Authors:  C C Lang; A M Choy; I S Henderson; W J Coutie; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-02       Impact factor: 6.124

View more
  28 in total

Review 1.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

2.  Clinical experience of chest pain in adults with congenital heart disease in a single tertiary center.

Authors:  June Huh; I-Seok Kang; Heung Jae Lee; Seung Woo Park
Journal:  Pediatr Cardiol       Date:  2010-02-09       Impact factor: 1.655

3.  Accessory pathway location affects brain natriuretic peptide level in patients with Wolff-Parkinson-White syndrome.

Authors:  Yosuke Nakatani; Koji Kumagai; Shigeto Naito; Kohki Nakamura; Kentaro Minami; Masahiro Nakano; Takehito Sasaki; Koichiro Kinugawa; Shigeru Oshima
Journal:  J Interv Card Electrophysiol       Date:  2016-11-04       Impact factor: 1.900

4.  Right ventricular function in grown-up patients after correction of congenital right heart disease.

Authors:  Julia Lemmer; Grit Heise; Axel Rentzsch; Petra Boettler; Titus Kuehne; Karl Otto Dubowy; Brigitte Peters; Bjoern Lemmer; Alfred Hager; Brigitte Stiller
Journal:  Clin Res Cardiol       Date:  2010-10-28       Impact factor: 5.460

5.  4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.

Authors:  Michelle Carroll-Turpin; Valeria Hebert; Tanya Chotibut; Heather Wensler; Dallas Krentzel; Kurt James Varner; Brendan R Burn; Yi-Fan Chen; Fleurette Abreo; Tammy Renee Dugas
Journal:  Toxicol Sci       Date:  2015-06-26       Impact factor: 4.849

Review 6.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

7.  Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect.

Authors:  Jingdong Ding; Genshan Ma; Yaoyao Huang; Xiaoli Zhang; Biao Liu; Fengxiang Lu
Journal:  Cardiovasc Ultrasound       Date:  2008-07-07       Impact factor: 2.062

Review 8.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

9.  Right ventricular dysfunction and B-type natriuretic peptide in asymptomatic patients after repair for tetralogy of Fallot.

Authors:  Christian Apitz; Ludger Sieverding; Heiner Latus; Anselm Uebing; Stefan Schoof; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2009-05-28       Impact factor: 1.655

Review 10.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.